NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market

Edwards got FDA OK for heart clip; it enters a market led by AtriCure, adding competition but not changing the outlook much.

Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market
Credit: Edwards Lifesciences
Already have an account? Sign in.
06/29/2026 · 3:42 PM
ATRC
/ Read more

Feed↓

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada
07/21/2026 · 3:53 PM

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada

Roth Capital maintains a Buy rating with a $9 price target despite the post-deal share decline.

/ Subscriber only
BMO Bullish on Trevi Therapeutics: Sees First-in-Class Potential for Haduvio in IPF Cough
07/21/2026 · 1:18 PM

BMO Bullish on Trevi Therapeutics: Sees First-in-Class Potential for Haduvio in IPF Cough

BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.

/ Subscriber only
TSMC Announces Up to 10% Price Hike for Advanced Chips Starting 2027
Featured/ 07/21/2026 · 12:54 PM

TSMC Announces Up to 10% Price Hike for Advanced Chips Starting 2027

Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe